UNVERIFIEDSingle SourceSTAT+: The next step of site-neutral, and a fiery PBM hearingStat News|7/20/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about a telehealth firm and patient safety, PBMs overcharging, and moreStat News|7/20/2026
UNVERIFIEDSingle SourceSTAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputerStat News|7/20/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about rising drug shortages, GSK coughing up a trial loss, and moreStat News|7/17/2026
UNVERIFIEDSingle SourceSTAT+: Can ultrasound unlock the power of gene therapy? A startup makes big claimsStat News|7/17/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and moreStat News|7/16/2026
UNVERIFIEDSingle SourceSTAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvalsStat News|7/16/2026
UNVERIFIEDSingle SourceSTAT+: At key hearing, Kennedy’s ouster of former CDC director looms over nominee to replace herStat News|7/15/2026
UNVERIFIEDSingle SourceCassidy grills Trump nominee on past vaccine comments in heated exchangeStat News|7/15/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and moreStat News|7/15/2026
UNVERIFIEDSingle SourceSTAT+: Anthropic’s Claude Science is coming for Kendall SquareStat News|7/14/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and moreStat News|7/14/2026